Intervention Review

Spironolactone for hypertension

  1. Josh Batterink2,
  2. Sarah N Stabler3,
  3. Aaron M Tejani1,*,
  4. Curt T Fowkes2

Editorial Group: Cochrane Hypertension Group

Published Online: 4 AUG 2010

Assessed as up-to-date: 10 MAR 2010

DOI: 10.1002/14651858.CD008169.pub2


How to Cite

Batterink J, Stabler SN, Tejani AM, Fowkes CT. Spironolactone for hypertension. Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD008169. DOI: 10.1002/14651858.CD008169.pub2.

Author Information

  1. 1

    Fraser Health Authority, Pharmacy Services, Burnaby, BC, Canada

  2. 2

    Northern Health Authority, Pharmacy, Prince George, BC, Canada

  3. 3

    University of BC, Faculty of Pharmaceutical Sciences, Vancouver, BC, Canada

*Aaron M Tejani, Pharmacy Services, Fraser Health Authority, 3935 Kincaid Street, Burnaby, BC, V5G 2X6, Canada. Aaron.Tejani@fraserhealth.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 4 AUG 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sarah C West, Aaron M Tejani, Sarah N Stabler, Matthew P Tsang, Eplerenone for hypertension, The Cochrane Library,